Touro Scholar
NYMC Faculty Publications

Faculty

5-25-2016

Glycosphingolipid GM3 is Indispensable for Dengue Virus
Genome Replication
Kezhen Wang
Gang Bian
Tingting Feng
Penghua Wang
New York Medical College

Yunsen Li

See next page for additional authors

Follow this and additional works at: https://touroscholar.touro.edu/nymc_fac_pubs
Part of the Virology Commons

Recommended Citation
Wang, K., Wang, J., Sun, T., Bian, G., Pan, W., Feng, T., . . . Dai, J. (2016). Glycosphingolipid GM3 is
indispensable for dengue virus genome replication. International Journal of Biological Sciences, 12(7),
872-883. doi:10.7150/ijbs.15641

This Article is brought to you for free and open access by the Faculty at Touro Scholar. It has been accepted for
inclusion in NYMC Faculty Publications by an authorized administrator of Touro Scholar. For more information,
please contact touro.scholar@touro.edu.

Authors
Kezhen Wang, Gang Bian, Tingting Feng, Penghua Wang, Yunsen Li, and Jianfeng Dai

This article is available at Touro Scholar: https://touroscholar.touro.edu/nymc_fac_pubs/123

Int. J. Biol. Sci. 2016, Vol. 12

Ivyspring
International Publisher

872

International Journal of Biological Sciences

Research Paper

2016; 12(7): 872-883. doi: 10.7150/ijbs.15641

Glycosphingolipid GM3 is Indispensable for Dengue
Virus Genome Replication
Kezhen Wang1#, Juanjuan Wang1#, Ta Sun1, Gang Bian1, Wen Pan1, Tingting Feng1, Penghua Wang2,
Yunsen Li1 and Jianfeng Dai1
1.
2.
#

Institutes of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou 215123, P.R. China
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.

These two authors contribute equally.

 Corresponding authors: Jianfeng Dai, Ph.D., daijianfeng@suda.edu.cn and Yunsen Li, Ph.D., yunsenli@suda.edu.cn; Institutes of Biology and Medical
Sciences, Soochow University, Building 703, 199 Ren-ai Road, Suzhou 215123, P.R. China; Tel/Fax: (86-512) 6588 2472
© Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See
http://ivyspring.com/terms for terms and conditions.

Received: 2016.03.24; Accepted: 2016.05.03; Published: 2016.05.25

Abstract
Dengue virus (DENV) causes the most prevalent arthropod-borne viral disease of humans
worldwide. Glycosphingolipids (GSLs) are involved in virus infection by regulating various steps of
viral-host interaction. However, the distinct role of GSLs during DENV infection remains unclear.
In this study, we used mouse melanoma B16 cells and their GSL-deficient mutant counterpart
GM95 cells to study the influence of GSLs on DENV infection. Surprisingly, GM95 cells were highly
resistant to DENV infection compared with B16 cells. Pretreatment of B16 cells with synthetase
inhibitor of GM3, the most abundant GSLs in B16 cells, or silencing GM3 synthetase T3GAL5,
significantly inhibited DENV infection. DENV attachment and endocytosis were not impaired in
GM95 cells, but DENV genome replication was obviously inhibited in GM95 cells compared to B16
cells. Furthermore, GM3 was colocalized with DENV viral replication complex on endoplasmic
reticulum (ER) inside the B16 cells. Finally, GM3 synthetase inhibitor significantly reduced the
mortality rate of suckling mice that challenged with DENV by impairing the viral replication in
mouse brain. Taken together, these data indicated that GM3 was not required for DENV
attachment and endocytosis, however, essential for viral genome replication. Targeting GM3 could
be a novel strategy to inhibit DENV infection.
Key words: Flavivirus; Dengue Virus; Glycolipid; Glycosphingolipids; Lipid Synthesis; Viral Replication

Background
Dengue virus (DENV) is a mosquito-borne
pathogen responsible for outbreaks of dengue fever
(DF), dengue hemorrhagic fever (DHF), and dengue
shock syndrome (DSS). DENV is widely distributed
in subtropical and tropical areas of the world and
infect 50–100 million individuals every year[1, 2].
However, there is no specific antiviral drug against
DENV[3, 4].
Like other flaviviruses, DENV is internalized via
receptor-mediated endocytosis[5-7]. Then the viral
genome is released and translated at the rough
endoplasmic reticulum (ER) to produce a polyprotein,
which is cleaved into three structural proteins (the
capsid protein C, membrane protein M, and the

envelope protein E), and seven nonstructural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5)[6, 8].
After initial translation, viral RNA replication takes
place in a structure called replication complex (RC) on
the ER membranes. RC is composed of viral RNA,
nonstructural proteins and other host factors[9-11].
DENV NS4A induced ER membrane alterations,
which may serve as a scaffold to anchor the viral RC
[12]. Some flaviviruses have been reported to exploit
cellular lipids to assemble their RC[13]. For example,
HCV RNA replication occurs on the membranous
web (MW) containing the high levels of cellular lipid
phosphatidylinositol-4-phosphate (PI4P)[14]. DENV
NS3 recruited fatty acid synthase (FASN) to the sites
http://www.ijbs.com
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DENV
replication,
resulting
in
lipid
biosynthesis[15]. West Nile virus (WNV) redistributes
cholesterol to the sites of viral replication[16].
However, mechanisms of cellular lipids involved in
DENV replication complex formation remain largely
unclear.
Glycosphingolipids
(GSLs),
amphipathic
molecules consisting of a ceramide and sugar
residues, are ubiquitous cellular components of
eukaryotic plasma membranes[17-19]. Besides of the
roles in cell adhesion and signal transduction, GSLs
have been shown to participate in various stages of
life cycle of distinct viruses[20, 21]. Most of the current
reports focused on the role of GSLs and their
metabolites on the virus attachment and entry of
specific cells[20, 21]. For example, galactosylceramide
(GalCer) and sulfatide interact with HIV gp120 or
gp41, and act as an alternate receptor for HIV in
CD4-negative cells[22]; GD1a and GT1b are used as
entry receptors by murine polyoma virus[23];
Gangliosides are ligands for human noroviruses
(NoVs)[24], rotaviruses[25] and parvovirus B19[26].
Gangliosides are required for productive cell entry of
rotaviruses[25], and ceramide also plays roles in entry
and egress processes of Japanese encephalitis virus
(JEV)[27].
As GSLs have biophysical properties of
membrane bending and stretching, they are also
involved in viral maturation and budding[20, 21]. For
example, HIV-1 selectively assemble and bud from
GSL-enriched lipid microdomains, resulting in
incorporation of GSL into the viral membrane[28]. A
recent study by Konan and colleagues showed that a
GSL -binding protein, FAPP2, recruited GSLs to the
HCV replication complex, and critical for modulation
of HCV genome replication[14]. However, the distinct
role of GSLs on DENV infection is unclear.
GM95 is a mutant cell line of B16 cells that do not
synthesize GSLs including GM3 due to deficient in
ceramide glycosyltransferase (GlcT-1), the first step of
glucosylceramide (GlcCer) synthesis[29]. As GM3 is
the most abundant GSLs in B16 cells, we focus on the
function of GM3 on DENV replication in the present
study.

Methods
Ethics Statements- All animal experiments were
conducted according to the Guide for the Care and
Use of Medical Laboratory Animals (Ministry of
Health, People’s Republic of China, 1998) and
approved by the Animal Care and Use Committee as
well as the Ethical Committee of Soochow University.
Virus, cells and replicons- DENV type 2
(DENV-2) New Guinea C (NGC) strain was
propagated in mosquito C6/36 cells (from ATCC®

873
CRL-1660). B16 and GM95 cells were initially from Dr.
Steven B Levery (University of New Hampshire) and
maintained in our lab in DMEM supplemented with
10 %( v/v) FBS and 1 %( v/v) penicillin-streptomycin.
Cells were infected with DENV-2 at a multiplicity of
infection (MOI) of 1, unless otherwise stated.
DNA-based replicons (for DENV type 1) expressing
secreted Gaussia luciferase (DGL2 and DGL2-mut)
[30], were generously provided by Dr. Takayuki
Hishiki (Kyoto University, Kyoto, Japan).
Inhibitors and antibodies- Pharmacological
inhibitors 1-phenyl-2-palmitoylamino-3-morpholino1-propanol (PPMP) and Soyasaponin-I were
purchased from Sigma Aldrich. Primary antibodies
Mouse
anti-DENV
(Santa
Cruz),
mouse
anti-GM3 (NeuAc) mAb M2590 (Cosmo Bio Co. Ltd,
Tokyo, Japan) and secondary antibodies FITC labeled
Donkey anti-mouse IgG (Jackson ImmunoResearch),
Goat anti-Mouse IgM Secondary Antibody, FITC
conjugate (Pierce) were used in this study.
TCID50 assay and viral growth kinetics- B16
and GM95 cells were seeded in 24-well plate and
infected with DENV for 12, 24 and 48 hrs,
respectively. The cell-free supernatants were collected
and the DENV titers were assayed with a TCID50
assay according to standard protocols on Vero cells
(ATCC® CCL-81). The viral replication levels inside
cells, in terms of the transcript levels of the DENV-2
envelop gene (E), were quantified by quantitative
reverse transcription PCR (qRT-PCR) and normalized
to mouse beta actin gene.
Preparation of Rhodamine-labeled DENVViruses were concentrated by ultracentrifugation and
then labelled with
Rhodamine
dye
using
a NHS-Rhodamine antibody labelling kit (Pierce)
according to manufacturer's protocol. Briefly, purified
viruses were dialyzed in 0.67M borate buffer and
incubate in the dark at room temperature with
NHS-Rhodamine Reagent. After 1 hr, the
unincorporated dye was removed by resin filter.
Rhodamine-Labelled viruses were used immediately.
Virus binding and endocytosis assay- For virus
binding assay, B16 and GM95 cells were incubated
with DENV (MOI=10) at 4 ℃ for 1 hr. The cells were
washed three times with pre-cold PBS to remove
unbound viruses. Two approaches were used to
determine the virus binding efficiency: (a) cells were
lysed directly for qRT-PCR analysis of virus E gene
copy; (b) cells were lysed and the number of bound
virus was measured by TCID50 assay.
To assess viral internalization efficiency (virus
endocytosis assay), B16 and GM95 cells were
incubated with DENV (MOI=10) at 37 ℃ for 30 min.
Cells were washed with PBS and treated with 0.5%
trypsin for 10 min to remove the viruses that not
http://www.ijbs.com
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internalized. Finally, cells were washed with PBS and
harvested by low-speed centrifugation. Intracellular
viral RNA was quantified by qRT-PCR.
For a visualized DENV binding and endocytosis
assay, the same experimental procedure was
performed using a Rhodamine-labeled DENV as
described above. Cells were incubated with labelled
virus for 1 hr at 4 ℃ (for virus binding) or incubated at
37 ℃ for 30 min (for virus internalization). Cells were
fixed in 4% formaldehyde, permeabilized with 0.1%
Triton X-100 and then examined by inverted
fluorescence microscope (cell nucleus were
stained with DAPI).
RT-PCR of virus negative strand RNA
(-ssRNA)- To generate the cDNA template specific for
DENV negative strand RNA, the total RNA was
extracted from DENV-infected cells at 6, 12 and 24 hr
postinfection. Forward PCR primer for DENV E gene
was used to transcribe the cDNA for negative strand
RNA using First Strand cDNA Synthesis Kit
(Thermo). DENV E gene and mouse beta actin were
amplified by PCR with rTaq DNA polymerase
(TaKaRa
Biotechnology),
and
detected
by
electrophoresis on a 2% agarose gel.
DENV replicon Gaussia luciferase reporter
assay- In 48-well plates, 50% confluent B16 and GM95
cells were transfected with 100 ng of DGL2-WT or
DGL2-mut replicon plasmids. For the Gaussia
luciferase assay, culture supernatant were collected at
different time points ( 0, 24, 48, 72 and 96 hr post
transfection) and luciferase was measured using
BioLux™ Gaussia Luciferase Assay Kit (New England
Biolabs) according to the manufacturer’s instructions.
RNA interference and qRT-PCR- siRNA
targeting mouse T3gal5 gene and negative controls
were ordered from Ribotask (Guangzhou, China). B16
cells were seeded in 24-well plates prior to
transfection and the siRNA were transfected into cells
using Lipofectamine 2000 (Invitrogen) according to
the
manufacturer's
protocol.
After
24
hrs, siRNA-transfected cells were then infected with
DENV. Viral replication were measured by
amplifying the DENV-2 E gene and normalized to
mouse beta actin. (siRNA and oligo-primer sequences
for this study were shown in Table S1 in the
supplemental materials).
Pharmaceutical inhibitors treatment and cell
viability assay- Two inhibitors were used for
inhibiting ganglioside biosynthesis. PPMP, an
inhibitor of glucosylceramide synthase that catalyses
the first step of ganglioside biosynthesis;
Soyasaponin-I, a sialyltransferase inhibitor, inhibits
the last step of synthesis of GM3. B16 cells were
cultured in 48-well plates, 1μM PPMP (or 100 μM
Soyasaponin-I) was added to cells. At 48 hr post
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treatment, cells were washed three times with PBS
and then infected with DENV. The viral replication
efficiency was measured as described above.
For cell viability assay, B16 cells were cultivated
in 96-well plates to 90% confluency and treated with
the inhibitor compounds as described concentration
above. Following treatment at 37 °C for 48 hrs, cell
viability was evaluated using the CellTiter-Glo®
Luminescent Cell Viability Assay (Promega)
according to the manufacturer’s instructions.
Addition of exogenous GM3 to GM95 cells- To
evaluate the effect of exogenous ganglioside GM3 on
GM95 cells during DENV infection, GM3 (bovine,
purity >98%, from Matreya LLC.) was added to the
GM95 culture medium at a final concentration of 100
μg/μl. Unincorporated gangliosides were removed
by washing twice with 20% FBS-DMEM prior to
DENV infection. Then, the cells were infected with
DENV-2 and viral replication efficiency was
measured as described above.
Immunofluorescence staining and confocal
microscopy- B16 and GM95 cells grown on 48-well
plate were infected with DENV-2. At 24 hr
postinfection, the cells were fixed with 4%
paraformaldehyde (PFA) for 10 min, permeabilized
with 0.1% Triton X-100 in PBS, and then blocked with
5% FBS in PBS. Plates were incubated with a DENV
envelope monoclonal antibody overnight at 4 °C,
washed, and then incubated with FITC goat
anti-mouse secondary antibody for 1 hr at room
temperature. Samples were analyzed by an inverted
fluorescence microscope.
To analyze of the changes of GM3 in B16 cells
upon DENV infection, DENV-2 infected or
non-infected B16 cells were fixed and immunostained
with antibody against GM3. Then images were
collected using confocal fluorescence microscopy.
For co-localization study, B16 cells were
transfected with YFP-KDEL (an ER lumen protein)
and infected with DENV-2. 48 hr postinfection, cells
were fixed with 4% PFA. DENV NS4A protein and
GM3 were probed with primary antibodies (rabbit
IgG anti-DENV NS4A and mouse anti-GM3 mAb )
and stained with Dy light 649 donkey anti-rabbit IgG
and TRITC labeled anti-mouse IgM, respectively. The
localizations of DENV NS4A, GM3 and ER inside cells
were then examined by confocal microscope.
GSL extraction, Mass Spectrometry, and
thin-layer chromatography (TLC)- GSLs extraction
was performed as described previously[31]. Briefly,
cell pellets (1x108) were extracted by sonication with
each of the following different solvents: (i)
chloroform/methanol (1:1, v/v); (ii) isopropanol/
hexane/water (55:25:20, v/v/v). Supernatants were
dried and whole lipids were dissolved with
http://www.ijbs.com
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chloroform/methanol/water (30:60:8, v/v/v) and
then applied to a DEAE Sephadex A-25 (Sigma, St.
Luis, MO, USA) on a glass column (Internal
diameter×Length, 5×80 mm) for separation of neutral
and acidic lipid fraction. The acidic lipid fraction was
dried, dialyzed and lyophilized.
GSLs were completely methylated as described
previously[31, 32]. Methylated GSLs were analyzed
by LTQ-XL mass spectrometer (Thermo Fischer
Scientific, Waltham) in the positive ion mode ( ion
spray voltage 3.5 kV, capillary voltage 35 V, capillary
temperature 350 ℃, injection time 100 ms, activation
time 30 min, and isolation width m/z 1.5).
Acid GSLs were further analyzed by thin-layer
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chromatography (TLC) as described [29]. The purified
acid GSLs were developed on TLC plates of silica gel
60 (Merck) with chloroform/methanol/0.25%
CaCl2˙H2O (50:40:10, v/v/v). The plate was sprayed
with a resorcinol/H2SO4 reagent and then heated at
110 ℃ for 30 min. The purified ganglioside GM3
(Matreya LLC, Pleasant Gap, PA, USA) was used as
standard.
DENV infection of suckling mice- Breeder
BALB/c mice were purchased from Shanghai SLAC
Laboratory animal CO. LTD. Each 3- or 4-day-old
suckling mouse was inoculated intracerebrally with
100 PFU of DENV-2 as previously described[33],
together with or without 15 μg of GM3 synthetase
inhibitor soyasaponin-I. Survival of
mice were monitored daily and the
DENV replication level in cerebrum at
day 2 and day 4 postinfection were
measured by qRT-PCR method
described above.
Statistical analysis- Statistical
significances were calculated with an
unpaired two tailed Student’s t- test
and Log-rank (Mantel-Cox) Test (for
survival data only) using Prism 5
software (GraphPad).

Results
GM95 cells are resistant to
DENV infection
GM95 cells, a mutant B16
melanoma cell line, are incapable of
synthesizing GSLs due to a defective
GlcT-1 gene. As shown in Fig. 1A,
GSL GM3 was highly expressed in
wild type cells, but not in GM95 cells.

Figure 1. GM95 cells were resistant to DENV
infection. (A) Immunofluorescence analysis of GM3 in B16
and GM95 cells. B16 and GM95 cells were fixed and
immunostained with GM3 monoclonal antibody. The images
were collected using confocal fluorescence microscopy. (B)
Growth curves of DENV-2 in B16 and GM95 cells. The viral
burdens were analyzed by measuring the virus E gene copy
using qRT-PCR, and normalized to mouse beta actin. (C)
B16 and GM95 cells were seeded in 24-well plate and
infected with DENV for 12, 24 and 48hrs, respectively. The
cell-free supernatants were collected and the DENV titers
were assayed with a TCID50 assay on Vero cells. Results
were expressed as the mean + the SEM. * p < 0.05 and ** p
< 0.01 (t-test). Representative results from at least 3
independent experiments. (D) The supernatants from Fig.
1C were used to test cell pathogenic effect (CPE) on Vero
cells. Supernatants from infected B16 cells, but not from
infected GM95 cells, had significantly cell pathogenic effect
on Vero cells.
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To determine the roles of GSLs on DENV
infection, we exposed the B16 and GM95 cells to
DENV-2. Viral infection level was measured by
amplifying the viral envelope gene (E) copies using
qRT-PCR at 0, 24, 48 and 72 hr postinfection and
normalized to mouse beta-actin gene. As shown in
Fig. 1B, B16 cells were highly susceptible to DENV
infection, while GM95 cells were resistant to DENV
infection. To further test whether GSLs impact
production of infectious virus particles, the titers of
virus in the supernatant of infected B16 and GM95
cells were measured by TCID50 assay. The numbers
of DENV virions in cell supernatants from GM95 cells
were much lower than that from B16 cells (Fig. 1C). As
shown in Fig. 1D, supernatants from infected B16 cells
caused significantly cell pathogenic effect (CPE) on
Vero cells. However, supernatants from infected
GM95 cells did not cause noticeable cell death. Taken
together, these data suggested that GM95 cells were
resistant to DENV infection.
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Inhibition of GM3 synthesis impedes DENV
infection
To inhibit GSLs metabolism, inhibitors PPMP
and Soyasaponin-I were used to treat B16 cells. PPMP
is a glucosylceramide synthase inhibitor, and deplete
GSLs production by inhibiting GlcT-1 activity.
Soyasaponin-I, a specific sialytransferase inhibitor,
inhibits the last step of synthesis of GM3. As shown in
Fig. 2A and B, DENV RNA levels were reduced more
than 50% following the treatment of PPMP or
Soyasaponin-I. We have verified that the inhibitor
treatment has a negligible impact on cell viability as
determined using the CellTiter-Glo Luminescent Cell
Viability Assay (Promega) (Fig. 2C and D). To further
confirm the role of GM3 on DENV infection, GM3
synthetase was silenced by siRNA targeting mouse
T3gal5 gene (mt3gal5) (Fig. 2E). Consistent with the
data shown in Fig. 2B, the intracellular viral loads
were decreased in GM3 synthetase knockdown cells
(Fig. 2F). Moreover, exogenous ganglioside GM3
added to GM95 cells partially restored the DENV
infection (Fig. 2G). These data suggested that
GM3 played important roles in DENV
infection.

Figure 2. Inhibition of GM3 synthesis impeded DENV infection.
(A) A glucosylceramide synthase inhibitor, PPMP, inhibited DENV
replication in B16 cells. (B) Soyasaponin-I, the GM3 synthetase inhibitor,
inhibited DENV replication in B16 cells. (C, D) Viability of B16 cells treated
with PPMP (C) or Soyasaponin-I (D). (E) The RNAi efficiency of mt3gal5
siRNA was tested in B16 cells. (F) DENV replication was inhibited in
mt3gal5 knockdown B16 cells. (G) Exogenous ganglioside GM3 added to
GM95 cells partially restored the DENV infection. Results were expressed
as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test). Representative
results from at least 3 independent experiments.

GM3 synthesis is upregulated in DENV
infected cells
To explore whether the expression of
GM3 changed upon DENV infection,
immunofluorescence assay was performed
with immunofluorescence staining using GM3
mAbs in B16 cells. As shown in Fig. 3A, the
production of GM3 was significantly higher in
DENV infected B16 cells. The result was
further confirmed by mass spectrometry and
thin layer chromatography analysis. As shown
in Fig. 3B, the GM3 specific m/z peaks (1358.00
and 1468.08) were significantly higher in
infected B16 cells compared with non-infected
cells. In a TLC analysis, the fraction of GM3
was increased in the infected cells compared
with non-infected cells (Fig. 3 C and D). In line
with these results, the mRNA level of GM3
synthetase gene mT3gal5 in B16 cells was
http://www.ijbs.com
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significantly increased post DENV infection as
determined by qRT-PCR and normalized to mouse
beta-actin gene (Fig. 3E). These data suggested that
GM3 production was increased in DENV infected B16
cells, further indicating that GM3 is important in
DENV infection.

GM3 does not influence binding and
endocytosis of DENV
To assess whether the GM3 was necessary in
early stage of viral infection, the amount of
membrane-bound and internalized viruses were
measured by qRT-PCR of virus E gene and
Rhodamine-labeled virus imaging. The amount of
viruses attached to B16 and GM95 cells was also
analyzed by TCID50 assay on Vero cells. For virus
binding assay, B16 and GM95 cells were incubated
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with DENV (MOI=10) at 4 ℃ for 1 hr. The results
suggested that no significant differences in the
efficiency of virus binding between B16 and GM95
cells (Fig. 4, A-C). To quantity the viruses that entered
into the cells, the viruses were incubated with cells at
37 ℃ for 30 min and then the cells were treated with
trypsin. As shown in Fig. 4D and 4E, trypsin, but not
PBS, could effectively remove the virions which just
binding to the cell membrane. After trypsin treatment,
the viral RNA could still be detected in GM95 cells,
with a comparable level of those in B16 cells (Fig. 4F).
The Rhodamine-labeled DENV were also obviously
detected inside the GM95 cells in the virus
endocytosis assay (Fig. 4G). These results suggested
that GM3 was not involved in the virus binding and
internalization.

Figure 3. GM3 synthesis was upregulated in DENV infected cells. (A) Immunofluorescence analysis of GM3 in DENV infected and non-infected B16 cells. GM3 mouse
mAb and DENV NS3 mAb were used to perform the experiment. (B) Mass spectrometry analysis of GSLs in DENV infected and non-infected B16 cells. Both m/z peaks (1358.0
and 1468.08) represented GM3. (C) The GM3 fractions from DENV-infected and noninfected B16 cells were detected on TLC plates. Purified GM3 were served as a standard.
(D) Relative amount of GM3 fractions from Fig. 3C by density analysis. (E) The mRNA expression level of GM3 synthetase mt3gal5 at different time points after DENV infection,
normalized to mouse beta actin gene. Results were expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test). Representative results from at least 3 independent
experiments.
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Figure 4. GM3 was not necessary for DNEV binding and endocytosis. (A, B) B16 and GM95 cells were incubated with DENV (MOI=10) at 4 ℃ for 1 hr. The cells were
washed three times with pre-cold PBS to remove unbound viruses. The amount of membrane-bound DENV as measured by qRT-PCR of DENV E gene RNA (A) and TCID50
assay (B). (C) 4 ℃ binding assay with Rhodamine-labeled DENV in B16 and GM95 cells (cell nucleus were stained with DAPI). (D, E) The amount of viral RNA copies in B16 (D)
and GM95 (E) cells with or without trypsin treatment. The results confirmed that trypsin treatment could efficiently remove DENV virions that not been internalized. (F) The
amount of internalized DENV in B16 cells and GM95 cells as measured by qRT-PCR of DENV E gene RNA. (G) The amount of internalized Rhodamine-labeled DENV in B16 cells
and GM95 cells as analyzed via an inverted fluorescence microscope.

http://www.ijbs.com
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GM3 is indispensable for DENV genome
replication
The replication of the positive-strand RNA of
DENV is semi-conservative, and viral (-) strand RNA
serves as a template for the synthesis of new (+)
strand RNA. Therefore, the detection of viral (-)
strand RNA is indicative for DENV replication. Total
RNA was isolated from infected B16 and GM95 cells
for indicated time points and transcribed into (-)
cDNA with forward primer of DENV E gene. During
6 to 24 hr postinfection, the amount of negative
strands in infected B16 cells was significantly
increased, but not in infected GM95 cells (Fig. 5A). In
addition, qRT-PCR quantitation of negative strand
RNA in B16 and GM95 cells at 24 hr postinfection also
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suggested that there was no detectable (-) strand
subgenomic RNA in GM95 cells (Fig. 5B). In order to
better
understand
the
kinetics
of
DENV RNA replication,
a
wild-type
DENV
DNA-based replicon (DGL2) or a NS5 mutant
replicon (DGL2 mut)[30] was transfected into B16 and
GM95 cells. As shown in Fig. 5C and 5D, the DENV
replicon replication was severely impaired in GM95
cells. In line with this, when Soyasaponin-1 (Fig. 5E)
and PPMP (Fig. 5F) was added to B16 cells, the DENV
replicon replications were obviously decreased.
Meanwhile, exogenous ganglioside GM3 added to
GM95 cells partially restored the DENV replicon
replication (Fig. 5G). These results demonstrated that
GM3 was necessary for DENV genome replication.

Figure 5. GM3 was indispensable for DENV genome replication. (A, B) Semi-quantified PCR (A) and qRT-PCR (B) analysis of negative strand RNA (-ssRNA) of DENV
in infected B16 and GM95 cells. (C, D) The replication kinetics of DENV replicon (DGL2 or DGL2 mut) in B16 and GM95 cells. Cells supernatant was harvested at different time
points and Gaussia luciferase was measured. (E, F) DGL2 replicon replication was inhibited by Soyasaponin-I (E) and PPMP (F) in B16 cells, individually. (G) Exogenous ganglioside
GM3 added to GM95 cells partially restored the DGL2 replicon replication in GM95 cells. Results were expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test).
Representative results from at least 3 independent experiments.
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GM3 is associated with DENV replication
complex
Then we examined whether GM3 co-localized
with DENV replication complex. Studies have been
reported that DENV RNA replication takes place in
replication complex (RC) on ER, which comprise the
viral RNA template with the nonstructural proteins
and presumably associated with virus-induced
intracellular membrane structures. GM3 was stained
in B16 cells with or without DENV infection and the
ER structure were indicated by a YFP-labeled ER
marker. As shown in Fig. 6A, GM3 is mainly located
on the cell membrane. After DENV infection, the
amount of GM3 significantly increased and some of
them were localized on ER. Immunofluorescence
staining also suggested that GM3 was partially
colocalized with DENV NS4A, the non-structural
protein that anchored the RC to ERs, in B16 cells (Fig.
6B). These data suggested that GM3 colocalized with
DENV replication complex in ER.
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Soyasaponin-I reduces the mortality rate of
DENV infected suckling mice
To test whether GM3 synthetase inhibitor
soyasaponin-I could protect mice against DENV
infection, 3- or 4-day-old suckling mice were
inoculated intracerebrally with 100 PFU of DENV-2
together with or without 15 μg soyasaponin-I,
respectively. As shown in Fig. 7A, soyasaponin-I
significantly reduced the mortality rate of suckling
mice suffered with DENV infection. To test whether
soyasaponin-I protect mice against DENV infection
via inhibiting the viral replication, the DENV
replication level in cerebral tissues were analyzed at
day 2 and day 4 postinfection. As shown in Fig. 7B,
the DENV replications in mouse brain were
significantly impaired in soyasaponin-I treated mice.
These data further suggested that GM3 was
indispensable for DENV replication.

Figure 6. GM3 was associated with DENV replication complex. (A) GM3 was co-localized with ER marker (YFP-KDEL) in DENV infected B16 cells. B16 cells were
transfected with YFP-KDEL (an ER lumen protein as ER marker) and infected with DENV-2. After 48 hr, the cells were fixed. GM3 were stained mouse mAb followed by a TRITC
labeled goat anti mouse IgM secondary Ab. The lower panel showed a detailed co-localization of GM3 and ER marker. (B) GM3 was colocalized with DENV NS4A in DENV
infected B16 cells. B16 cells were infected with DENV-2 for 48 hrs. Then the cells were fixed and labeled with GM3 mouse mAb and NS4A rabbit Ab followed by fluorescence
labeled secondary Abs.
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Figure 7. Soyasaponin-I reduced the mortality rate of DENV infected suckling mice. (A) Survival rate of the suckling mice received intracerebral injection of 100 PFU
of DENV-2 with or without 15 μg soyasaponin-I. Injected suckling mice were monitored daily for signs of illness until day 15. PBS or Soyasaponin-I was injected into suckling mice
separately as the controls. Results were analyzed by Log-rank (Mantel-Cox) Test. ***p =0.0004. (B) Soyasaponin-I impaired the DENV replication in mouse brain. RNA was
isolated from cerebral tissues of DENV-2 infected suckling mice with or without 15 μg soyasaponin-I at day 2 and day 4 postinfection. And the qRT-PCR was performed as
described before. Results were expressed as the mean + the SEM. * p < 0.05 and ** p < 0.01 (t-test).Representative results from at least 3 independent experiments.

Discussion
GSLs are amphipathic lipids consisting of
oligosaccharide and ceramide moieties. Ceramide, the
common precursor of GSLs, is synthesized at the
membranes of the ER. Newly synthesized ceramide
transports from ER to the trans-Golgi regions, where
it is converted to the most GSLs by
glycosyltransferases. Finally, the de novo biosynthesis
of GSLs reaches the plasma membrane via vesicular
exocytotic membrane flow[19]. Viruses are not
capable of replicating themselves independently, and
must utilize host cell cofactors to facilitate its entry,
replication, assembly and budding of virions. Among
the host factors required by viruses, lipids like GSLs,
play important roles in viral infection [20, 21]. The
vast majority of articles showed that viruses exploit
GSLs for viral binding, entry, assembly or release. For
example, HIV-1 entry to CD4+ T cells via its envelope
protein gp120 recognizes of CD4 on target cells, this
interaction gives rise to a conformational change in
gp120 third variable loop (V3) that allow for binding
to GalCer, globotriaosylceramide (Gb3) and GM3. In

addition, GalCer can support HIV entry into non-CD4
expressing cells through binding to gp120 [22, 34-36].
Several members of the polyomavirus (Py), such as
simian virus 40 (SV40), BK virus and Py viruses, also
bind to specific gangliosides (sialic acid-containing
GSLs) on cell membrane to cause infection[23]. In the
case of virus budding, HIV-1 preferentially buds from
GSL-enriched lipid microdomains on the plasma
membrane. The HIV-1 virions contain higher levels of
GM3 and boosts virus capture by mature dendritic
cells (MDCs)[37]. However, the distinct role of GSLs
in the DENV life cycle is still unclear.
In the present study, we discovered that DENV
infection severely impaired in GSL deficient GM95
cells when compared with wild type B16 cells.
Interestingly, DENV binding and entry were not
affected in GM95 cells, suggesting that GSLs were not
necessary for virus binding and endocytosis.
However, Chie Aoki and colleagues reported that
DENV-2 could recognize the neutral GSLs nLc4Cer
(Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ1-1’Cer) and L-3
(GlcNAcβ1-3Manβ1-4Glcβ1-1’Cer) expressed on the
cell surface of DENV-susceptible cells[38]. Whether
http://www.ijbs.com
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those specific GSLs were involved in DENV infection
are still unknown. In our study, we focused on the
role of GM3, the most dominant GSL in B16 cells.
Actually, we did not detect any Gb3 and LC3 in B16
cells by mass spectrometry. We found that GM3 was
not required for DENV binding and endocytosis.
To test whether GM3 play a role in DENV
genome replication, DNA-based DENV replicon
DGL-2 and DGL-2 mut[30] were used to assess the
dynamic replication of DENV in B16 and GM95 cells.
Without any binding or entry issue, transfected
DENV replicon replicated much more efficiently in
B16 cells compared to GM95 cells. Replication of
DENV RNA occurs in ER membrane–associated
replication complex (RC) composed of viral replicase
proteins, viral RNA and other host factors [10, 39].
Subcellular colocalization analysis showed that GM3
colocalized with the DENV NS4A, NS3 and ER
marker in DENV infected B16 cells, suggesting that
GSLs may participate in organization of DENV RCs.
Recently, GSLs were reported to play a key role in
Hepatitis C virus (HCV) replication. Knockdown of
four-phosphate adaptor protein 2 (FAPP2) could
attenuate HCV infectivity and impede HCV RNA
replication. In addition, HCV increased LacCer and
Gb3 levels, and addition of these lipids to
FAPP2-depleted
cells
partially
rescued
replication[14]. The results were in line with our
findings that GM3, a major subtype of GSLs, was
indispensable for DENV genome replication.
Although both HCV and DENV belong to the family
Flaviviridae, the replication of DENV shows significant
difference from that of HCV[10]. DENV’s NS4A
induced rearrangements of the ER membranes after
infection
[40].
Electron
tomography
and
three-dimensional reconstructions analyzes showed
that DENV-induced ER-derived structure are termed
vesicle packets and convoluted membranes, while
HCV
infection
induces
double-membrane
vesicles[10].
Up to date, the roles of GSLs during DENV
infection are largely unknown. Our findings showed
that GM3 was not required for DENV’s binding and
entry, but indispensable for its replication. GM3
synthetase inhibitor significantly reduced the
mortality rate of DENV infected mice. Therefore,
inhibiting GM3 biosynthesis could be a new strategy
for control of DENV infection.
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